IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option
IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option
Beschrijving
In this podcast, Dr Edgar Lerma and Dr Dana Rizk discuss IgA nephropathy and the key data on sparsentan from the phase 3 PROTECT trial.
Probeer 14 dagen gratis
€ 9,99 / maand na proefperiode. · Elk moment opzegbaar
- Podcasts die je alleen op Podimo hoort
- 20 uur luisterboeken / maand
- Gratis podcasts
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option community!